Cargando…
Layer-By-Layer Nanoparticle Vaccines Carrying the G Protein CX3C Motif Protect against RSV Infection and Disease
Respiratory syncytial virus (RSV) is the single most important cause of serious lower respiratory tract infections in young children; however no effective treatment or vaccine is currently available. Previous studies have shown that therapeutic treatment with a monoclonal antibody (clone 131-2G) spe...
Autores principales: | Jorquera, Patricia A., Oakley, Katie E., Powell, Thomas J., Palath, Naveen, Boyd, James G., Tripp, Ralph A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693221/ https://www.ncbi.nlm.nih.gov/pubmed/26473935 http://dx.doi.org/10.3390/vaccines3040829 |
Ejemplares similares
-
Nanoparticle Vaccines Encompassing the Respiratory Syncytial Virus (RSV) G Protein CX3C Chemokine Motif Induce Robust Immunity Protecting from Challenge and Disease
por: Jorquera, Patricia A., et al.
Publicado: (2013) -
Microparticle RSV Vaccines Presenting the G Protein CX3C Chemokine Motif in the Context of TLR Signaling Induce Protective Th1 Immune Responses and Prevent Pulmonary Eosinophilia Post-Challenge
por: Powell, Thomas J., et al.
Publicado: (2022) -
Anti-G protein antibodies targeting the RSV G protein CX3C chemokine region improve the interferon response
por: Bergeron, Harrison C., et al.
Publicado: (2023) -
RSV Replication, Transmission, and Disease Are Influenced by the RSV G Protein
por: Bergeron, Harrison C., et al.
Publicado: (2022) -
Respiratory Syncytial Virus (RSV) G Protein Vaccines With Central Conserved Domain Mutations Induce CX3C-CX3CR1 Blocking Antibodies
por: Bergeron, Harrison C., et al.
Publicado: (2021)